NO20084852L - MGLUR5 modulatorer V - Google Patents
MGLUR5 modulatorer VInfo
- Publication number
- NO20084852L NO20084852L NO20084852A NO20084852A NO20084852L NO 20084852 L NO20084852 L NO 20084852L NO 20084852 A NO20084852 A NO 20084852A NO 20084852 A NO20084852 A NO 20084852A NO 20084852 L NO20084852 L NO 20084852L
- Authority
- NO
- Norway
- Prior art keywords
- mglur5 modulators
- mglur5
- modulators
- novel compounds
- therapy
- Prior art date
Links
- 101150087728 Grm5 gene Proteins 0.000 title 1
- 102100038357 Metabotropic glutamate receptor 5 Human genes 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US79766306P | 2006-05-05 | 2006-05-05 | |
| PCT/US2007/067371 WO2007130824A2 (en) | 2006-05-05 | 2007-04-25 | Fused heterocylic compounds and their use as mglur5 modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20084852L true NO20084852L (no) | 2009-01-14 |
Family
ID=38668441
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20084852A NO20084852L (no) | 2006-05-05 | 2008-11-18 | MGLUR5 modulatorer V |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20070259860A1 (es) |
| EP (1) | EP2027129A2 (es) |
| JP (1) | JP2009536213A (es) |
| KR (1) | KR20090018935A (es) |
| CN (1) | CN101484455A (es) |
| AR (1) | AR060811A1 (es) |
| AU (1) | AU2007248292A1 (es) |
| BR (1) | BRPI0710980A2 (es) |
| CA (1) | CA2650255A1 (es) |
| CL (1) | CL2007001178A1 (es) |
| EC (1) | ECSP088884A (es) |
| IL (1) | IL194815A0 (es) |
| MX (1) | MX2008013834A (es) |
| NO (1) | NO20084852L (es) |
| RU (1) | RU2008141511A (es) |
| TW (1) | TW200808800A (es) |
| UY (1) | UY30308A1 (es) |
| WO (1) | WO2007130824A2 (es) |
| ZA (1) | ZA200809019B (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200821305A (en) | 2006-10-05 | 2008-05-16 | Astrazeneca Ab | MGluR5 modulators |
| WO2009054790A1 (en) * | 2007-10-26 | 2009-04-30 | Astrazeneca Ab | Amide linked heteroaromatic derivatives as modulators of mglur5 |
| WO2009054786A1 (en) * | 2007-10-26 | 2009-04-30 | Astrazeneca Ab | 1,2,4-triazole aryl n-oxides derivatives as modulators of mglur5 |
| WO2009054787A1 (en) * | 2007-10-26 | 2009-04-30 | Astrazeneca Ab | 1,2,4-triazole carboxylic acid derivatives as modulators of mglur5 |
| WO2009054793A1 (en) * | 2007-10-26 | 2009-04-30 | Astrazeneca Ab | Thiophene 1,2,4-triazole derivatives as modulators of mglur5 |
| WO2009054785A1 (en) * | 2007-10-26 | 2009-04-30 | Astrazeneca Ab | 1,2,4-triazole ether derivatives as modulators of mglur5 |
| AU2008317544A1 (en) * | 2007-10-26 | 2009-04-30 | Astrazeneca Ab | Amino 1,2,4-triazole derivatives as modulators of mGluR5 |
| TW200924774A (en) * | 2007-10-26 | 2009-06-16 | Astrazeneca Ab | Fused pyrrolidine 1,2,4-triazole derivatives as modulators of mGluR5 |
| KR20110101164A (ko) * | 2008-12-18 | 2011-09-15 | 아스트라제네카 아베 | 1-〔5-(3-클로로-페닐)-이소옥사졸-3-일〕-에타논 및 (ｒ)-1-〔5-(3-클로로-페닐)-이속사졸-3-일〕-에탄올의 신규 제조 방법 |
| JP5620129B2 (ja) * | 2009-03-19 | 2014-11-05 | 富士フイルム株式会社 | 光学フィルム、位相差板、楕円偏光板、液晶表示装置、及び化合物 |
| CA2767764A1 (en) | 2009-07-13 | 2011-01-20 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and use thereof |
| WO2011082010A1 (en) | 2009-12-29 | 2011-07-07 | Eli Lilly And Company | Tetrahydrotriazolopyridine compounds as selective mglu5 receptor potentiators useful for the treatment of schizophrenia |
| KR20130139895A (ko) | 2010-09-02 | 2013-12-23 | 다케다 야쿠힌 고교 가부시키가이샤 | 경도인지 장애의 치료 또는 예방용 융합 트리아졸 |
| MX361136B (es) | 2013-01-23 | 2018-11-28 | Astrazeneca Ab | Compuestos quimicos. |
| EP2857387A1 (en) | 2013-10-07 | 2015-04-08 | Boehringer Ingelheim International Gmbh | Process for manufacturing 1,6-dihydro-6-oxo-4-pyridazine carboxylic acid |
| TWI891782B (zh) | 2020-05-06 | 2025-08-01 | 德商拜耳廠股份有限公司 | 作為殺蟲劑之新穎雜芳基三唑化合物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3896900A (en) * | 1999-03-19 | 2000-10-09 | Knoll Pharmaceutical Company | Treatment of pain |
| MXPA05001592A (es) * | 2002-08-09 | 2005-05-05 | Astrazeneca Ab | Oxadiazoles como moduladores de receptor-5 de glutamato metabotropico. |
| WO2004014902A2 (en) * | 2002-08-09 | 2004-02-19 | Astrazeneca Ab | Compounds having an activity at metabotropic glutamate receptors |
| RU2372347C2 (ru) * | 2004-02-18 | 2009-11-10 | Астразенека Аб | Соединения тетразола и их применение в качестве антагонистов метаботропного рецептора глутамата |
| MY152888A (en) * | 2004-02-18 | 2014-11-28 | Astrazeneca Ab | Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists. |
| US7585881B2 (en) * | 2004-02-18 | 2009-09-08 | Astrazeneca Ab | Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
-
2007
- 2007-04-24 TW TW096114393A patent/TW200808800A/zh unknown
- 2007-04-25 AR ARP070101784A patent/AR060811A1/es unknown
- 2007-04-25 AU AU2007248292A patent/AU2007248292A1/en not_active Abandoned
- 2007-04-25 KR KR1020087029721A patent/KR20090018935A/ko not_active Withdrawn
- 2007-04-25 UY UY30308A patent/UY30308A1/es not_active Application Discontinuation
- 2007-04-25 CA CA002650255A patent/CA2650255A1/en not_active Abandoned
- 2007-04-25 MX MX2008013834A patent/MX2008013834A/es not_active Application Discontinuation
- 2007-04-25 BR BRPI0710980-6A patent/BRPI0710980A2/pt not_active IP Right Cessation
- 2007-04-25 US US11/790,429 patent/US20070259860A1/en not_active Abandoned
- 2007-04-25 RU RU2008141511/04A patent/RU2008141511A/ru not_active Application Discontinuation
- 2007-04-25 CL CL2007001178A patent/CL2007001178A1/es unknown
- 2007-04-25 JP JP2009509957A patent/JP2009536213A/ja active Pending
- 2007-04-25 EP EP07811855A patent/EP2027129A2/en not_active Withdrawn
- 2007-04-25 WO PCT/US2007/067371 patent/WO2007130824A2/en not_active Ceased
- 2007-04-25 CN CNA2007800254542A patent/CN101484455A/zh active Pending
-
2008
- 2008-10-21 ZA ZA200809019A patent/ZA200809019B/xx unknown
- 2008-10-22 IL IL194815A patent/IL194815A0/en unknown
- 2008-11-12 EC EC2008008884A patent/ECSP088884A/es unknown
- 2008-11-18 NO NO20084852A patent/NO20084852L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2007248292A1 (en) | 2007-11-15 |
| JP2009536213A (ja) | 2009-10-08 |
| AR060811A1 (es) | 2008-07-16 |
| AU2007248292A8 (en) | 2008-12-04 |
| TW200808800A (en) | 2008-02-16 |
| CA2650255A1 (en) | 2007-11-15 |
| CN101484455A (zh) | 2009-07-15 |
| EP2027129A2 (en) | 2009-02-25 |
| KR20090018935A (ko) | 2009-02-24 |
| ECSP088884A (es) | 2008-12-30 |
| UY30308A1 (es) | 2007-11-30 |
| MX2008013834A (es) | 2008-11-10 |
| WO2007130824A3 (en) | 2008-05-22 |
| US20070259860A1 (en) | 2007-11-08 |
| RU2008141511A (ru) | 2010-06-20 |
| BRPI0710980A2 (pt) | 2011-05-31 |
| CL2007001178A1 (es) | 2008-01-18 |
| ZA200809019B (en) | 2009-08-26 |
| IL194815A0 (en) | 2009-08-03 |
| WO2007130824A2 (en) | 2007-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20084852L (no) | MGLUR5 modulatorer V | |
| NO20084850L (no) | MGLUR5 modulatorer I | |
| NO20084923L (no) | N-(2-thiazolyl)-amid derivater som GSK-3 inhibitorer | |
| BRPI0915084B8 (pt) | composto, e, composição farmacêutica | |
| EA200901157A1 (ru) | Конденсированные кольцевые гетероциклические модуляторы киназы | |
| EA200870193A1 (ru) | Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение | |
| NO20090628L (no) | Pyridizinon derivativater | |
| NO20074823L (no) | Rasagilin-formuleringer med forbedret innholdsensartethet | |
| EA200900023A1 (ru) | Применение замещенных 2-аминотетралинов для изготовления лекарственного средства для предупреждения, облегчения и/или лечения разных видов боли | |
| MA32161B1 (fr) | Formes de rifaximine et utilisations de celles-ci | |
| EA201190235A1 (ru) | Замещенные 1-цианоэтилгетероциклилкарбоксамидные соединения 750 | |
| UA94129C2 (ru) | Соединения для ингибирования митоза | |
| ATE502921T1 (de) | Substituierte indole | |
| NO20090295L (no) | Substituerte heteroarylderivater | |
| EA201070327A1 (ru) | Катехоламиновые производные и их пролекарства | |
| CL2008003848A1 (es) | Compuestos derivados de fenilo o heteroarilo bis-sulfonilamino sustituidos, inhibidores de prostaglandina e sintasa-1 microsomal; composicion farmaceutica; procedimiento de preparacion; procedimiento de preparacion de la composicion farmaceutica; y uso en el tratamiento del dolor agudo o cronico, dolor nociceptivo o dolor neuropatico. | |
| EA200870185A1 (ru) | Комбинации ингибиторов ang2 и vegf | |
| EA201001329A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
| DK2024352T3 (da) | Glucopyranosylsubstituerede benzoenitrilderivater, farmaceutiske sammensætninger indeholdende sådanne forbindelser, deres anvendelse og fremgangsmåde for deres fremstilling | |
| CL2008001367A1 (es) | Compuestos derivados de heterociclos nitrogenados sustituidos; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar una infeccion bacteriana. | |
| CY1108794T1 (el) | Σπειροκυκλικα παραγωγα κυκλοεξανιου | |
| EA201001332A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
| MX2009003227A (es) | Moduladores de los receptores de glutamato metabotropicos 5(mglur5). | |
| EA201001330A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
| JO2682B1 (en) | Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |